- To be registered as an official research organization by the
National Assembly Secretariat... Expected to become Korea's leading
medical think tank
- Planning to initiate global multinational clinical projects
in digital therapeutics
- Establishing a future medical system centered around
prevention and management... Expanding digital medical
services
SEOUL,
South Korea, April 19,
2024 /PRNewswire/ -- Amid growing concerns about
a medical crisis as a result of acute conflict between the
government and the medical community due to an increase in the
quota of medical school admission, the regular seminar of the Korea
Medical Innovation Research Forum (KMIRF) kicked off; experts from
various fields of the medical field gathered to prepare for future
medical reform. It was held at Andaz Seoul Gangnam on the
17th of April.
KMIRF was launched last March by experts in various fields of
the medical industry, and is co-represented by Dae Hee Kang, former dean of Seoul National University College of Medicine, current
president of the Telemedicine Society, and Jong Yoon Lim, former chairman of the Bio
Association, registered director of Hanmi Science and chairman of
COREE Group.
Medical experts who serve as steering and working committee
members of each division, including co-representatives Dae Hee Kang and Jong
Yoon Lim, gathered and led a heated discussion for medical
reform. In addition, the newly elected People Power Party
Representatives Cheolsoo Ahn,
Soomin Park, and Democratic Party
Representative Do-geol Ahn (via video conference) attended and
advocated the Forum at the National Assembly level.
Co-representative Jong Yoon Lim
mentioned the urgency of addressing immediate medical reform in his
opening speech and said, "Medical intellectual property rights
belong to the country and the people, and in order to improve the
country's global competitiveness and future value in medicine, we
need to go beyond Healthcare 4.0 and create a national and
permanent proposition." "We will definitely propose future medical
innovation policies," he said. "We plan to hold regular seminars
for KMIRF at least six times a year and frequently put forward
future medical innovation policies with the cooperation of experts
and policymakers in each field."
In his congratulatory address, Rep. Cheolsoo Ahn said, "The paradigm of health care
has completely changed through COVID-19, and now, as part of
medical reform, we need to establish a 'future-oriented legal
system' that recognizes upcoming technological and social changes,
and eliminates regulations that may become obstacles in advance."
He emphasized, "It is time to play a role in preparing ahead for
the future," and added, "I hope that KMIRF will be play a central
role for this change."
Co-representative Dae Hee Kang
emphasized the importance and revitalization of digital healthcare
and personalized preventive medicine through a presentation on the
topic of 'Future Medicine and Digital Healthcare', as well as
laying out the purpose and role in the establishment of KMIRF along
with future goals. He also explained the operation plan and said,
"We plan to register as an official research group within the
National Assembly Secretariat and will fulfill our role as Korea's
representative medical think tank." Industrial Division Director
Mahn Soon Hwang gave a presentation
on 'Bio-Industry Trends' and emphasized the importance of the
country, companies, and investments for the development of the
bio-ecosystem and medical reform.
In addition, a free discussion was commenced in relation to
digital health, especially digital therapeutics, as with new
therapeutics. It was suggested that regulatory bodies should be
able to determine the price and fee structure that will compensate
private companies for their enormous investment in clinical
research at the time of approval, and came to a consensus that the
tone should be set globally in which any country applying for
clinical trials or regulatory approval should be adequately
recompensed according to such profit structure logic. As the first
step in accomplishing this vision, we have decided to pursue a
project regarding multi-national digital therapeutics' clinical
trials around the world.
Hee Hwang, CEO of Kakao
Healthcare, expressed his encouragement by saying that he deems it
as a very timely strategy and said, "As a healthcare expert, I will
utilize my expertise to help with the research group's first
project."
Hong Taek Yong, a professor at
Hanyang University (former
1st Vice Minister of Science and Technology), said, "I
am looking forward to the role of Hanyang
University at a time when innovative policies need to be
promoted in order to incorporate the remarkable advancements in
science and technology into healthcare, and I will do my best to
contribute as a member."
Professor In Taek Lim of
Catholic University (former Director of
the Health and Medical Policy Office of the Ministry of Health and
Welfare) said, "In order to effectively respond to the rapidly
changing medical environment and technological changes, our medical
system must develop into human-centered digital-based medical care,
and the launch of KMIRF at this time is critical." "We will strive
to ensure that the research committee stands at the center of
this," he said.
Meanwhile, the KMIRF aims to create a healthcare ecosystem where
the government, medical community, companies, and citizens can
coexist, establishing a future healthcare system centered around
prevention and management, and resolving intergenerational and
regional medical service imbalances through digital medicine, and
other platforms. It will be a proponent in presenting ways to
expand access to medical services. In addition, it plans to serve
as a bridge through which medical policymakers and decision-makers
can come together to commonly recognize and empathize with the all
related policies that are put forth.
KMIRF is comprised of policy, human resources, and industry
divisions; while Hong Taek Yong,
former 1st Vice Minister of Science and ICT, leads the
policy division, Yu Mi Seo, former
11th director of the Korea Education and Research
Information Service, heads the human resources division, and
Mahn Soon Hwang, current CEO of
Korea Investment Partners leads the industrial division.
[Appendix] Korea Medical Innovation Research
Forum Steering Committee
Name
|
Profile
|
Dae Hee Kang
|
Former Dean of Seoul
National University College of Medicine / Current President of the
Telemedicine Society
|
Jong Yoon
Lim
|
Former Chairman of the
Bio Association / Current Chairman of COREE Group / Current
Internal Director of Hanmi Science
|
Hong Taek
Yong
|
Former First Vice
Minister of Science and ICT / Current Professor at Hanyang
University
|
In Taek Lim
|
Former Director of
Health and Medical Policy, Ministry of Health and Welfare / Current
Research Professor, Graduate School of Health and Medical
Management, Catholic University of Korea
|
Oh Sang Kwon
|
Former Deputy Director
of the Ministry of Food and Drug Safety / Current Visiting
Professor at Seoul National University
|
Kil Won Kim
|
Current President of
Korea Medical Biotechnology Association
|
Yu Mi Seo
|
Former 11th Director of
Korea Education and Research Information Service
|
Jong Il Kim
|
Current Dean of
Department of Medical Sciences, Seoul National
University
|
Yoo Suk Hong
|
Current Dean of College
of Engineering, Seoul National University
|
Mahn Soon
Hwang
|
Current CEO of Korea
Investment Partners
|
Sung Kwan
Jung
|
Current Medical Vice
Chairman of the Korean Hospital Association / Chairman of the Board
of Directors of Our Children's Hospital, Our Children's Medical
Foundation
|
Byung Ho Nam
|
Former Professor at
Boston University / Current CEO of Herings, Co. Ltd.
|
Hee Hwang
|
Current CEO of Kakao
Healthcare
|
Young Shin
Lee
|
Current CEO of Seers
Technology
|
Sung Jun Han
|
Current CEO of Avixgen,
CTO of Dx&Vx
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/inaugural-korea-medical-innovation-research-forum-regular-seminar-a-success-302121951.html
SOURCE Korea Medical Innovation Research Forum